Prothena | PRTA - 운영 비용





운영 비용 변화 날짜
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Akebia Therapeutics USD 63.08M 8.26M 2025-12
ALKERMES USD 1.75B 1.43B 2026-03
Alnylam Pharmaceuticals USD 898.54M 66.78M 2026-03
Amgen USD 4.78B 1.12B 2026-03
Biogen USD 1.96B 69.6M 2026-03
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Exelixis USD 362.75M 21.35M 2025-12
Immunic USD 23.33M 2.67M 2025-12
Incyte USD 5.62B 4.5B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
MacroGenics USD 53.32M 13.68M 2025-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Prothena USD 27.23M 14.95M 2025-12
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03
Xoma USD 22.84M 1.67M 2024-09